Lung

Roche to halt lung most cancers trial

12:40 04/07/24 Max: 26,740.00 Min: 26,420.00 Roche is to finish a novel lung most cancers remedy trial, the Swiss firm...

Roche's anti-TIGIT tiragolumab posts one other key examine fail in lung most cancers – FirstWord Pharma

Roche's anti-TIGIT tiragolumab posts one other key examine fail in lung most cancers  FirstWord Pharma

Nonlinear affiliation between PD-L1 expression ranges and the danger of postoperative recurrence in non-small cell lung most cancers

SufferersThe research inhabitants consisted of 647 sufferers who underwent lung most cancers resection on the NHO Kinki Chuo Chest Medical Middle (KCMC) between...

Roche Holding seen down on plan to halt lung most cancers drug trial – XM

Roche Holding seen down on plan to halt lung most cancers drug trial  XM

Hot Topics